Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing

Bacteremia Clinical Trial

Official title:

Bacteremia From Dental Extractions vs. Oral Hygiene

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00454285
• Other study ID #: 13559
• Secondary ID: R01DE013559-011R
• Status: Completed
• Phase: Phase 2
• Start date: January 2003
• Est. completion date: June 2006

Study information

• Verified date: December 2009
• Source: Wake Forest University Health Sciences
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The major purposes of this prospective, randomized, clinical study are to:

1. Determine and compare the true incidence, nature, magnitude, and duration (INMD) of bacteremia (bacteria found in the bloodstream) resulting from a highly invasive dental office procedure (tooth extraction) and a minimally invasive and naturally occurring source of bacteremia (tooth brushing);

2. Measure the effect of the American Heart Association's guidelines for amoxicillin prophylaxis (preventive treatment) on the INMD of bacteremia resulting from a single tooth extraction.

Description:

The use of antibiotic prophylaxis to prevent distant site infections (DSI) from oral pathogens remains a controversial issue in clinical practice. Little is known about the incidence, nature, and duration (IND) of bacteremia resulting from dental extractions or tooth brushing, either in the presence or absence of prophylactic antibiotic coverage. The purpose of this prospective, randomized, clinical study of 300 subjects is to characterize the bacteremia resulting from a highly invasive (single extraction) dental office procedure and a minimally invasive and naturally occurring source of bacteremia (i.e., tooth brushing). Subjects will be randomized into three equal groups: extraction with amoxicillin, extraction with placebo, and oral hygiene. The major goals are to: 1) improve our understanding of the IND of bacteremias from 10 specific oral pathogens (S. mitis, S. sanguis, S. oralis, S. intermedius, S. mutans, S. salivarius, F. nucleatum, A. Actinomycetemcomitans, E. corrodens and P. gingivalis) that have been reported to cause DSI; 2) measure the effect of the American Heart Association's guidelines for amoxicillin prophylaxis on the IND of bacteremia resulting from a single dental extraction. Blood for aerobic and anaerobic cultures will be drawn at six time points before, during, and following these oral procedures. We will employ a highly sensitive broth-based culturing system (i.e., BACTEC) and improve the specificity of the BACTEC results with the use of PCR sequence analysis. Detailed clinical information on the extent of disease in and around the involved teeth will determine the significance of local disease factors on the IND of the bacteremia from oral pathogens. Data from this study should have implications regarding future guidelines and standards of care concerning antibiotic prophylaxis for individuals currently felt to be at risk for DSI.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 290
• Est. completion date: June 2006
• Est. primary completion date: November 2005
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Subjects must have at least 10 teeth and the need for a dental extraction.

• Subjects will be accepted into the study regardless of the extent of their odontogenic and/or periodontal disease, to include Type I through IV American Association of Periodontists classification.

Exclusion criteria:

• Subjects who need surgical extractions that require initial removal of bone overlying the surface of a tooth.

• Subjects who have taken systemic antibiotics within the previous 2 weeks.

• Subjects who require antibiotic coverage, based on current practice guidelines, prior to invasive dental procedures (e.g., cardiac valve abnormalities).

.Subjects with active viral infectious disease (e.g., hepatitis).

• Subjects who are immunocompromised (e.g., organ transplant, HIV).

• Subjects classified as American Society of Anesthesiology Class III or higher (i.e., a patient with poorly-controlled systemic disease).

• Subjects with facial cellulitis.

• Subjects who have had any manipulation of the gingiva within 1 hr prior to the study(e.g., eating, tooth brushing, chewing gum).

• Subjects with a history of penicillin allergy.

• Subjects deemed by the clinician to have a bacterial infection.

• Subjects with a temperature of 100.5 degrees Fahrenheit or above.

• Venous access unavailable in non-dominant arm.

Related Conditions & MeSH terms

• Bacteremia

Intervention

Drug:
• Effect of Amoxicillin on bacteremia following a single-tooth extraction
Administer Amoxicillin 1 hour prior to single-tooth extraction.

Locations

Country	Name	City	State
United States	Carolinas Medical Center Dental Clinic	Charlotte	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Wake Forest University Health Sciences	National Institute of Dental and Craniofacial Research (NIDCR)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall incidence of bacteremia in three groups		Blood Draws at 0, 2.5, and 5 minutes; and at 20. 40, and 60 minutes.